Inventor · disambiguated record
Maria Hopkins
Also filed as: HOPKINS MARIA
19 granted patents·3 pending applications·39 citations·filing 2013–2024
92Inventor score
Files withTAKEDA PHARMACEUTICALS CO15ENVOY THERAPEUTICS INC2TAKEDA PHARMACEUTICAL2BROWN JASON W1HITCHCOCK STEPHEN1
Top patents by PatentIndex Score
22 records- 0188US9303045B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Apr 5, 2016·7 cites·11 claims
- 0287US9012447B25-HT3 receptor antagonistsENVOY THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·8 cites·15 claims
- 0386US9346829B25-HT3 receptor antagonistsHITCHCOCK STEPHEN·Filed 2015·Granted May 24, 2016·5 cites·2 claims
- 0485US9670229B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 6, 2017·3 cites·11 claims
- 0584US9770452B2Quinoxaline derivatives as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·4 cites·22 claims
- 0680US9487526B2Quinoxaline derivatives as GPR6 modulatorsENVOY THERAPEUTICS INC·Filed 2013·Granted Nov 8, 2016·5 cites·21 claims
- 0777US10179783B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 15, 2019·2 cites·8 claims
- 0875US10077266B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 18, 2018·1 cites·11 claims
- 0971US9708313B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsBROWN JASON W·Filed 2015·Granted Jul 18, 2017·1 cites·15 claims
- 1070US9181249B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Nov 10, 2015·1 cites·19 claims
- 1169US10738046B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 11, 2020·0 cites·21 claims
- 1268US10597392B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICAL CORPORATION LTD·Filed 2018·Granted Mar 24, 2020·1 cites·11 claims
- 1368US10407443B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·14 claims
- 1468US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 1565US10125145B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Nov 13, 2018·0 cites·12 claims
- 1663US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1763US2018072758A15ht3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 1862US9695195B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 4, 2017·0 cites·9 claims
- 1961US10406157B2Tetrahydropyridopyrazine modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·28 claims
- 2061US2025188037A1N-(pyrrolidin-3-yl or piperidin-4-yl)acetamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2151US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 2243US11426397B2Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 30, 2022·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →